Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PENICILLAMINE for Hepato-lenticular degeneration: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 146 adverse event reports in the FDA FAERS database where PENICILLAMINE was used for Hepato-lenticular degeneration.

Most Reported Side Effects for PENICILLAMINE

Side Effect Reports % Deaths Hosp.
Drug hypersensitivity 117 22.4% 0 23
Diarrhoea 76 14.6% 0 27
Nausea 76 14.6% 1 25
Off label use 73 14.0% 9 28
Acute kidney injury 69 13.2% 1 29
Hypersensitivity 69 13.2% 0 28
Drug intolerance 68 13.0% 1 24
Proteinuria 68 13.0% 0 24
Headache 64 12.3% 0 23
Chest pain 62 11.9% 0 24
Drug ineffective 59 11.3% 8 38
Anti-neutrophil cytoplasmic antibody positive vasculitis 56 10.7% 0 33
Arthralgia 56 10.7% 0 29
Joint swelling 55 10.5% 0 28
Treatment failure 52 10.0% 1 24

Other Indications for PENICILLAMINE

Product used for unknown indication (178) Rheumatoid arthritis (71) Scleroderma (20) Cystinuria (19) Systemic scleroderma (13) Nephrolithiasis (11)

Other Drugs Used for Hepato-lenticular degeneration

TRIENTINE TETRAHYDROCHLORIDE (125) TRIENTINE (122) ZINC (54) ZINC\ZINC (8) OLANZAPINE (5)

Related Pages

PENICILLAMINE Full Profile All Hepato-lenticular degeneration Drugs PENICILLAMINE Demographics PENICILLAMINE Timeline